U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

trilostane [Supplementary Concept]

inhibits conversion of pregnenolone to progesterone; adrenal blocking agent used in treatment of Cushing's syndrome

Date introduced: January 1, 1975

MeSH Unique ID: C009954

Registry Number: L0FPV48Q5R

Heading Mapped to:

Entry Terms:

  • 4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile
  • Modrenal
  • WIN 24,540

Previous Indexing:

Pharmacologic Action:

Supplemental Content

Loading ...